Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
CNOOC
00883
| (Q1)Nov 30, 2025 | (FY)Aug 31, 2025 | (Q4)Aug 31, 2025 | (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -100.10%-625.14K | 69.12%-652.8K | 89.85%-81.05K | 59.35%-192.43K | 35.61%-259.59K | 28.87%-312.42K | -176.97%-2.11M | -129.16%-798.32K | -178.33%-473.43K | 47.96%-403.13K |
| Net income from continuing operations | 8.55%-592.87K | 24.43%-1.46M | 102.38%20.19K | -52.69%-437.99K | 15.04%-392.59K | -95.03%-648.3K | -58.30%-1.93M | -116.24%-848.78K | 46.65%-286.85K | -105.71%-462.1K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --170 |
| Depreciation and amortization | 0.20%1.01K | 0.00%677 | -1,494.08%-2.36K | 498.22%1.01K | 494.71%1.01K | 498.22%1.01K | -13.32%677 | 503.57%169 | --169 | --170 |
| Asset impairment expenditure | ---- | --0 | ---- | ---- | ---- | ---- | --577.72K | ---- | ---- | ---- |
| Remuneration paid in stock | 76.19%134.07K | -29.10%184.35K | -73.64%10.41K | -13.90%46.37K | -50.39%51.48K | 20.92%76.09K | 29.08%260.02K | -44.33%39.47K | 13.42%53.86K | 24.94%103.76K |
| Deferred tax | --10.22K | 72.66%-199.55K | 58.93%-199.55K | --0 | --0 | --0 | -92.96%-729.83K | -1,894.86%-485.89K | ---91.39K | -11.14%-106.25K |
| Other non cashItems | ---- | --40.3K | --40.3K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | -168.62%-177.58K | 366.65%780.1K | 161.67%49.96K | 232.81%198.18K | 31.38%80.51K | 309.35%258.78K | -146.63%-292.56K | -1,645.05%-81.01K | -113.66%-149.22K | 111.40%61.28K |
| -Change in receivables | -106.17%-18.83K | 247.95%459.64K | 105.68%24.28K | 4,410.80%97.7K | -74.76%32.71K | 2,148.71%304.95K | -214.00%-310.67K | -629.76%-427.51K | 102.13%2.17K | 14.86%129.56K |
| -Change in prepaid assets | -129.63%-26.57K | 191.09%133.78K | -151.36%-29.68K | 102.27%3.44K | 265.38%70.34K | 926.79%89.67K | -748.82%-146.87K | 196.23%57.79K | -738.96%-151.28K | -84.13%-42.53K |
| -Change in payables and accrued expense | 13.24%-113.29K | 220.87%268.11K | -28.67%147.86K | 10,588.24%10.7K | 284.34%47.46K | -33.42%-130.59K | -74.85%83.56K | 297.70%207.29K | -100.01%-102 | 95.90%-25.75K |
| -Change in other working capital | -259.07%-18.89K | -200.00%-81.42K | ---92.5K | --86.34K | ---70K | ---5.26K | --81.42K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -100.10%-625.14K | 69.12%-652.8K | 89.85%-81.05K | 59.35%-192.43K | 35.61%-259.59K | 28.87%-312.42K | -176.97%-2.11M | -129.16%-798.32K | -178.33%-473.43K | 47.96%-403.13K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 5,108.79%367.7K | 72.29%-697.89K | 76.72%-429.76K | 50.38%-141.17K | 139.85%73.06K | 96.36%-7.34K | -28.66%-2.52M | -1,781.96%-1.85M | 34.48%-284.51K | 30.84%-183.33K |
| Net PPE purchase and sale | 919.15%60.13K | 56.18%-1.13M | 66.09%-625.93K | 12.42%-249.17K | 59.82%-58.3K | 97.64%-7.34K | 6.72%-2.59M | -940.81%-1.85M | 75.68%-284.51K | 45.26%-145.1K |
| Net other investing changes | --307.56K | 541.47%435.54K | --196.18K | --108K | 418.63%131.36K | ---- | -91.67%67.9K | --0 | ---- | ---41.23K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 5,108.79%367.7K | 72.29%-697.89K | 76.72%-429.76K | 50.38%-141.17K | 139.21%73.06K | 96.36%-7.34K | -28.66%-2.52M | -1,781.96%-1.85M | 34.48%-284.51K | 29.71%-186.33K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 101.95%775.98K | -45.84%1.65M | -92.74%151.61K | 197,155.56%425.64K | -28.08%684.61K | 384.24K | 23.43%3.04M | 37.95%2.09M | 96.86%-216 | -0.76%951.94K |
| Net issuance payments of debt | ---- | ---- | ---- | --410K | ---- | ---- | --0 | --0 | --0 | --0 |
| Net common stock issuance | 34.56%564.5K | -53.63%1.49M | -84.82%334K | --0 | -27.50%739.5K | --419.5K | 23.32%3.22M | 37.49%2.2M | --0 | 0.89%1.02M |
| Cash dividends paid | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --241.52K | ---- | ---- | 7,340.74%15.64K | ---- | --0 | ---- | ---- | 93.92%-216 | ---- |
| Interest paid (cash flow from financing activities) | ---- | ---33.82K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net other financing activities | 14.79%-30.04K | 203.62%186.93K | ---- | ---- | 19.35%-54.89K | ---35.26K | -32.31%-180.39K | ---- | ---- | -40.70%-68.07K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 101.95%775.98K | -45.84%1.65M | -92.74%151.61K | 197,155.56%425.64K | -28.08%684.61K | --384.24K | 23.43%3.04M | 37.95%2.09M | 96.86%-216 | -0.76%951.94K |
| Net cash flow | ||||||||||
| Beginning cash position | 289.74%397.36K | -93.98%101.96K | 14.88%756.56K | -53.09%664.52K | -84.21%166.44K | -93.98%101.96K | -13.22%1.7M | 4.85%658.57K | 204.77%1.42M | 93.31%1.05M |
| Current changes in cash | 704.07%518.53K | 118.54%295.41K | 35.47%-359.2K | 112.14%92.04K | 37.41%498.08K | 110.06%64.49K | -516.70%-1.59M | -152.17%-556.61K | -564.38%-758.16K | 550.10%362.47K |
| End cash Position | 450.27%915.89K | 289.74%397.36K | 289.74%397.36K | 14.88%756.56K | -53.09%664.52K | -84.21%166.44K | -93.98%101.96K | -93.98%101.96K | 4.85%658.57K | 204.77%1.42M |
| Free cash from | -198.67%-955.01K | 62.00%-1.79M | 73.26%-706.99K | 41.74%-441.6K | 42.02%-317.89K | 57.36%-319.76K | -32.94%-4.7M | -402.98%-2.64M | -33.99%-757.94K | 47.28%-548.24K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.